This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the efficacy and safety of renin inhibitors compared to angiotensin receptor blockers in people with primary hypertension.
Li, L. J., Chen, Y. J., Wang, G. M., Tang, W. L., & Wright, J. M. (2017). Renin inhibitors versus angiotensin receptor blockers for primary hypertension. Cochrane Database of Systematic Reviews, 2017(2). https://doi.org/10.1002/14651858.CD012570